Prostaglandin Levels in Pancreatic Cyst Fluid, Pancreatic Juice, and Resected Pancreatic Cysts


  • Study type

  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 07-008538
    Sponsor Protocol Number: 07-008538

About this study

The purpose of this study is to determine whether COX-2 enzyme activity in pancreatic cystic neoplasms is sufficient to justify a chemoprevention study.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria:

  1. Subject (or, if they are between 13 and 17 years of age, their parent or guardian) is able to give informed consent, and is not incarcerated;
  2. Subject is undergoing a clinically indicated endoscopic, percutaneous, or surgical procedure during which fluid will likely be obtained from a pancreas cystic structure or pancreatic fluid collection, OR
  3. Subject is undergoing a clinically indicated secretin-stimulated collection of pancreatic juice, with pancreatic juice collection from the duodenum via an endoscope or per-oral tube.

Exclusion Criteria:

  • None

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Mark Topazian, M.D.

Open for enrollment

Contact information:

Mark Topazian M.D.